Clinical Trials Directory

Trials / Completed

CompletedNCT02301832

Reliability of Sensor Spacing for NIRS in Traumatic Tibia Fractures

Reliability of Sensor Spacing for Near Infrared Spectroscopy in Traumatic Tibia Fractures: An Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
14 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is a study intended to evaluate a non-invasive device that uses light to measure the amount of oxygen in the muscles of injured and non-injured legs in specific situations. The name of this technology is NIRS (near-infrared spectroscopy). The goal of this study is to collect the information necessary to understand the use of the NIRS monitoring system to diagnose and direct treatment decisions in case of complications sometimes experienced in traumatic tibia fracture, such as excessive swelling called acute compartment syndrome (ACS).

Detailed description

This study seeks to further develop the use of NIRS technology in the diagnosis of acute compartment syndrome. NIRS values normally increase in traumatized legs compared to the contralateral uninjured leg or forearm, indicative of a hyperemic response. The investigators hopes to build upon the current knowledge and verify the ability to accurately detect ACS using two easily identified and accessible leg compartments, the anterior and superficial posterior utilizing the Nonin 7600 oximeter with the Sensor Model 8004CV. Additionally, since this device was originally designed with brain tissue in mind, the NIRS device will collect vital engineering data that will be used to validate the algorithm used to produce the oxygenation values in injured muscle tissue.

Conditions

Timeline

Start date
2014-12-01
Primary completion
2016-07-20
Completion
2016-07-20
First posted
2014-11-26
Last updated
2017-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02301832. Inclusion in this directory is not an endorsement.